Derivation of Hydroquinone to Produce Selective, Oxidatively Activated Chemotherapeutic Agents

Derivation of Hydroquinone to Produce Selective, Oxidatively Activated Chemotherapeutic Agents

Show other versions (1)

Bibliographic Details
Main Author:	Bell-Horwath, Tiffany R.
Language:	English
Published:	University of Cincinnati / OhioLINK 2014
Subjects:	Biochemistry Reactive Oxygen Species AML ROS Anti-Cancer Agent Drug Design Acute Myeloid Leukemia
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1406821452

Similar Items

Derivation of Hydroquinone to Produce Selective, Oxidatively Activated Chemotherapeutic Agents
by: Bell-Horwath, Tiffany R.
Published: (2014)

Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics
by: Michelle H. Lee, et al.
Published: (2019-08-01)

Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2
by: Rena G. Lapidus, et al.
Published: (2016-01-01)

Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling
by: Giedrė Valiulienė, et al.
Published: (2021-04-01)

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
by: Shi M, et al.
Published: (2019-09-01)

Development of a Selective and Stable Reactive Oxygen Species-activated Anti-Acute Myeloid Leukemia Agent and Localizing DNA Aptamer
by: Earnest, Kaylin G.
Published: (2018)

Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia
by: Silvia Trombetti, et al.
Published: (2021-02-01)

Caractérisation des NADPH oxydases et effet de leur inhibition dans les leucémies aigues myéloïdes
by: Dakik, Hassan
Published: (2017)

Cytotoxicity of Thioalkaloid-Enriched Nuphar lutea Extract and Purified 6,6′-Dihydroxythiobinupharidine in Acute Myeloid Leukemia Cells: The Role of Oxidative Stress and Intracellular Calcium
by: Danilenko, M., et al.
Published: (2022)

ROS/SUMO relationship in the chemotherapeutic treatment of Acute Myeloid Leukemia
by: Ristic, Marko
Published: (2015)

Novel Reactive Oxygen Species Activated Scaffold from Mechanism to Application
by: Zhu, Haizhou
Published: (2019)

Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
by: Charlotte Calvo, et al.
Published: (2021-02-01)

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
by: Francesco Tarantini, et al.
Published: (2021-08-01)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
by: Eric Grignano, et al.
Published: (2020-09-01)

The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun
by: Hayaa Moeed Alhuthali, et al.
Published: (2020-07-01)

CARACTERÍSTICAS CLÍNICO EPIDEMIOLOGICAS DE LOS PACIENTES CON LEUCEMIA AGUDA DEL SERVICIO DE HEMATOLOGIA DEL HOSPITAL ALMANZOR AGUINAGA ASENJO
by: Ana María Polo-Capuñay, et al.
Published: (2014-01-01)

Relationship between Oxidative Stress and Imatinib Resistance in Model Chronic Myeloid Leukemia Cells
by: Sylwester Głowacki, et al.
Published: (2021-04-01)

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)
by: Maryam Nourizadeh, et al.
Published: (2014-11-01)

Descriptive and Analytical Study of Acute Leukemia in Adults in Eastern Algeria
by: Fethi Tebbani, et al.
Published: (2020-12-01)

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
by: Weisberg E, et al.
Published: (2017-12-01)

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
by: Samantha L. Goldman, et al.
Published: (2019-03-01)

The clinical significance of γ-catenin in acute myeloid leukemia
by: Xu J, et al.
Published: (2016-06-01)

Acute Myeloid Leukemia (AML) as a model for cancer therapy
by: Farhad eRavandi
Published: (2012-10-01)

High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome
by: Fatere Seyedalipour, et al.
Published: (2017-07-01)

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
by: Bhuwan Giri, et al.
Published: (2019-05-01)

Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
by: Ashkan Emadi, et al.
Published: (2016-03-01)

Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia
by: Pourrajab F, et al.
Published: (2020-03-01)

Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-05-01)

Every‐other‐day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”
by: Nicola Di Renzo, et al.
Published: (2020-01-01)

Efficacy and toxicity of cladribine for the treatment of refractory acute myeloid leukemia: a meta-analysis
by: Zhou A, et al.
Published: (2019-05-01)

Therapies for acute myeloid leukemia: vosaroxin
by: Sayar H, et al.
Published: (2017-08-01)

Extramedullary Acute Myeloid Leukemia (AML): Leukemic Pleural Effusion, Case Report and Review of the Literature
by: Naveen ePemmaraju, et al.
Published: (2014-06-01)

Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
by: Kathrin Renner, et al.
Published: (2018-11-01)

Defining and treating older adults with acute myeloid leukemia who are ineligible for intensive therapies
by: Kristen ePettit, et al.
Published: (2015-12-01)

Cytogenetic and Morphological Analysis of De Novo Acute Myeloid Leukemia in Adults: A Single Center Study in Jordan
by: Ayesh M, et al.
Published: (2012-01-01)

Targeting a Common Enemy: Toxic Cellular Mechanism of Novel Anti-cancer Agents that Alter DNA and Transcription
by: Thowfeik, Fathima Shazna
Published: (2016)

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia
by: Mike N. Foster, et al.
Published: (2018-07-01)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
by: Bogdan Popescu, et al.
Published: (2019-12-01)

Targeting the Stress Response to ROS: Design and Development of Novel and Selective Anti-cancer Agents
by: Kizhakkekkara Vadukoot, Anish
Published: (2016)

Targeting the metabolism of leukemia stem cells as a novel therapeutic strategy
by: Neal M Davies, et al.
Published: (2013-02-01)

Cannot write session to /tmp/vufind_sessions/sess_fus5di725ib17cu1081g13r37l